Press Releases
Press Releases
Cytheris appoints Damian Marron as chief executive officer
Cytheris SA, a privately held clinical-stage biopharmaceutical company focused on treating lymphopenia driven diseases, announces today the appointment of Damian Marron as chief executive officer. Damian was previously CEO at Trophos SA. The first task...
Press Releases
Sanofi Submits Application for Regulatory Approval for Lyxumia for the Treatment of Type 2 Diabetes in Japan
Sanofi announced today that the marketing authorization application for Lyxumia, an investigational once-daily GLP-1 receptor agonist has been submitted for review to the Ministry of Health, Labour and Welfare in Japan. The application is...
Press Releases
FDA Correct to Delay Ruling on Gilead’s Controversial HIV ‘Prevention’ Pill
AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS nonprofit medical provider, welcomed the news today that the Food and Drug Administration (FDA) is delaying a ruling on and application by Gilead Sciences for the possible approval of the...
Press Releases
Problems Plague Medicare’s Method for Measuring Payment Errors American Association for Homecare
The American Association for Homecare reported in this week's Mobility Matters publication that the U.S. Department of Health and Human Services (HHS) has uncovered serious flaws in the methodology used to calculate the error rate on payments for...
Press Releases
Acquisition of the Healthcare Business of Thomson Reuters by Veritas Capital Completed
The previously announced $1.25 billion sale of the Thomson Reuters Healthcare business to an affiliate of Veritas Capital was completed today. The company’s many well-known brands, established in more than 30 years of leadership in the...
Press Releases
Allegro Diagnostics to Present at 2012 BIO International Convention
Allegro Diagnostics today announced its participation in the BIO Business Forum at the BIO International Convention, being held June 18-20 in Boston. Michael D. Webb, President and CEO, will present on Wednesday, June 20...
Press Releases
Japan Pharma Portfolio Finds Renewed Strength through Record Growth in 2012
Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), announced the successful 2012 return of the Japanese Pharma Portfolio of events to the Tokyo Big Sight Exhibition Centre in Tokyo, Japan with a record attendance...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read